Cathy Gwin
Senior Director, Communications
The Nuclear Threat Initiative (NTI) joined world leaders and policymakers at the 2026 Munich Security Conference (MSC), where NTI President and CEO Christine E. Wormuth and colleagues hosted events focused on reducing nuclear, biological, and emerging technology threats imperiling humanity.
Amid rapid advances in bioscience and as artificial intelligence reshapes global technological capabilities, the Nuclear Threat Initiative (NTI) and the China Arms Control and Disarmament Association (CACDA) are jointly calling for action to strengthen biosecurity and oversight and engage in responsible practices to prevent accidents or misuse.
NTI endorses the bipartisan Biosecurity Modernization and Innovation Act of 2026, led by Senators Tom Cotton (R-AR) and Amy Klobuchar (D-MN). This bill creates an important opportunity to incentivize a safe and secure U.S. bioeconomy through strengthened biosecurity policy.
New NTI | bio paper calls on tool developers and other AIxBio stakeholders to implement a managed access approach—allowing only validated users to access those biological AI models that contribute to biosecurity risks—to help reduce the risk that such tools will be deliberately misused to cause harm.
Students and early-career professionals from 19 countries across five continents entered the 2025 competition. The challenge called for innovative papers on how to define “biological weapons” in today’s ever evolving biothreat landscape.
Sign up for our newsletter to get the latest on nuclear and biological threats.
Sign up for regular updates on innovative, real-world solutions to existential threats.
{ location = 'https://www.nti.org/get-updates/' }, 300);">Get Updates